Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02407509
Title Phase I Trial of VS-6766 Alone and in Combination With Everolimus (RAF/MEK)
Acronym RAF/MEK
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Royal Marsden NHS Foundation Trust
Age Groups: adult | senior
Covered Countries GBR

Additional content available in CKB BOOST